chalcone has been researched along with Congenital Zika Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrade, CH; Brodsky, D; Caesar, LK; Cech, NB; de Oliveira, KZ; Ekins, S; Foil, DH; Guido, RVC; Jarmer, H; Laster, SM; Loh, B; Mesquita, NCMR; Mottin, M; Noske, GD; Oliva, G; Ramos, PRPS; Scholle, F; Sousa, BKP; Torres, PM; Zorn, KM | 1 |
| Almeida E Sá, FH; Brito Dos Santos, M; de Azevedo, FR; de Oliveira, TJS; Filho, EBA; Guimarães, AL; Pinto, ATM; Silva, ARN; Virginio, JF | 1 |
2 other study(ies) available for chalcone and Congenital Zika Syndrome
| Article | Year |
|---|---|
Chalcones from Angelica keiskei (ashitaba) inhibit key Zika virus replication proteins.
Topics: Angelica; Animals; Chalcone; Chalcones; Chlorocebus aethiops; Humans; RNA; RNA-Dependent RNA Polymerase; Vero Cells; Virus Replication; Zika Virus; Zika Virus Infection | 2022 |
A chalcone identified by in silico and in vitro assays possesses high larvicidal activity against Aedes aegypti.
Topics: Aedes; Animals; Chalcone; Chalcones; Humans; Insecta; Insecticides; Larva; Molecular Docking Simulation; Mosquito Vectors; Plant Extracts; Zika Virus; Zika Virus Infection | 2023 |